R. Hoyd
发表
M. Gerstein,
G. Weinstock,
S. Lou,
2020,
Genome Biology.
A. Amini,
S. Mohile,
D. Spakowicz,
2022,
Frontiers in Oncology.
D. Carbone,
D. Spakowicz,
R. Hoyd,
2022,
bioRxiv.
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival
G. Otterson,
Songzhu Zhao,
D. Spakowicz,
2022,
Journal of Cancer Research and Clinical Oncology.
Jing Zhang,
Donghoon Lee,
Mark Gerstein,
2020,
bioRxiv.
N. Denko,
D. Spakowicz,
R. Hoyd,
2022,
International journal of molecular sciences.
D. Carbone,
Lang Li,
C. Verschraegen,
2019,
BMC Cancer.
D. Spakowicz,
R. Hoyd,
C. Presley,
2021,
Journal of geriatric oncology.
D. Carbone,
B. Andersen,
G. Otterson,
2021,
Journal of Geriatric Oncology.
G. Otterson,
D. Spakowicz,
Lai Wei,
2020,
Cancer Immunology, Immunotherapy.
M. McCarter,
M. Churchman,
Y. Zakharia,
2023,
bioRxiv.
M. McCarter,
M. Churchman,
G. Riedlinger,
2023,
bioRxiv.
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival
G. Otterson,
Songzhu Zhao,
D. Spakowicz,
2022,
Journal of Cancer Research and Clinical Oncology.
E. Paskett,
D. Spakowicz,
R. Hoyd,
2022,
Journal of Geriatric Oncology.
M. Churchman,
R. Hoyd,
Fouad Choueiry,
2023,
bioRxiv.
E. Paskett,
R. Hoyd,
M. Grogan,
2024,
Frontiers in Aging.
G. Otterson,
Lai Wei,
R. Hoyd,
2023,
Cancer Immunology, Immunotherapy.
Jason V. Evans,
D. Carbone,
J. Zweier,
2023,
Journal of the National Cancer Institute.
George M. Slavich,
R. Hoyd,
Xin Zhou,
2024,
bioRxiv.
R. Hoyd,
M. Husain,
A. Tarhini,
2024,
Cancer research communications.
R. Hoyd,
Bingqiang Liu,
Zhaoqian Liu,
2024,
Advanced science.